Minimally Invasive Surgical Approach for the Treatment of Superior Mesenteric Artery Syndrome: Long-Term Outcomes.


Journal

World journal of surgery
ISSN: 1432-2323
Titre abrégé: World J Surg
Pays: United States
ID NLM: 7704052

Informations de publication

Date de publication:
06 2020
Historique:
pubmed: 8 2 2020
medline: 26 1 2021
entrez: 8 2 2020
Statut: ppublish

Résumé

Latero-lateral duodenojejunostomy is the treatment of choice for superior mesenteric artery syndrome (SMAS). The present study analyzes the long-term outcomes in 13 patients undergoing laparoscopic surgery for SMAS. A retrospective study of 10 females and three males undergoing surgery between 2001 and 2013 was performed. Demographic, clinical and radiologic data and long-term surgical outcomes were recorded. In 12 patients latero-lateral duodenojejunostomy and in one patient distal laparoscopic gastrectomy with Roux-en-Y reconstruction were performed. The median age was 24 years (20-28), and the median duration of symptoms was 24 months (5-24). The most frequent symptoms were abdominal pain (n = 11; 92.3%), nausea and vomiting (n = 10; 77%) and weight loss (n = 9; 69.2%). The median operating time was 98 min (86-138) and hospital stay was 3 days (1-14). No reconversions occurred, and one patient experienced gastric emptying delay in the immediate postoperative period with spontaneous resolution. In four patients, SMAS was associated with severe stenosis of the celiac trunk which was treated in the same operation, and four patients presented stenosis of the left renal vein (the "nutcracker" phenomenon). With a median follow-up of 94 months (SD 65.3), eight patients (61.5%) had excellent results. One patient had a relapse of symptoms 4 years after surgery requiring distal gastrectomy, two patients presented delay in gastric emptying following temporary improvement and one patient experienced no improvement. Latero-lateral duodenojejunostomy yields good results in SMAS although it requires other gastric motility disorders to be ruled out for appropriate treatment to be established.

Sections du résumé

BACKGROUND
Latero-lateral duodenojejunostomy is the treatment of choice for superior mesenteric artery syndrome (SMAS). The present study analyzes the long-term outcomes in 13 patients undergoing laparoscopic surgery for SMAS.
MATERIALS AND METHODS
A retrospective study of 10 females and three males undergoing surgery between 2001 and 2013 was performed. Demographic, clinical and radiologic data and long-term surgical outcomes were recorded. In 12 patients latero-lateral duodenojejunostomy and in one patient distal laparoscopic gastrectomy with Roux-en-Y reconstruction were performed. The median age was 24 years (20-28), and the median duration of symptoms was 24 months (5-24). The most frequent symptoms were abdominal pain (n = 11; 92.3%), nausea and vomiting (n = 10; 77%) and weight loss (n = 9; 69.2%). The median operating time was 98 min (86-138) and hospital stay was 3 days (1-14).
RESULTS
No reconversions occurred, and one patient experienced gastric emptying delay in the immediate postoperative period with spontaneous resolution. In four patients, SMAS was associated with severe stenosis of the celiac trunk which was treated in the same operation, and four patients presented stenosis of the left renal vein (the "nutcracker" phenomenon). With a median follow-up of 94 months (SD 65.3), eight patients (61.5%) had excellent results. One patient had a relapse of symptoms 4 years after surgery requiring distal gastrectomy, two patients presented delay in gastric emptying following temporary improvement and one patient experienced no improvement.
CONCLUSIONS
Latero-lateral duodenojejunostomy yields good results in SMAS although it requires other gastric motility disorders to be ruled out for appropriate treatment to be established.

Identifiants

pubmed: 32030438
doi: 10.1007/s00268-020-05413-5
pii: 10.1007/s00268-020-05413-5
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1798-1806

Références

Surg Endosc. 2017 Mar;31(3):1180-1185
pubmed: 27405482
Am J Surg. 1989 Jan;157(1):44-9
pubmed: 2910126
Neurogastroenterol Motil. 2006 Apr;18(4):263-83
pubmed: 16553582
Surg Radiol Anat. 2007 Oct;29(7):595-9
pubmed: 17646894
Surg Clin North Am. 2000 Feb;80(1):171-99
pubmed: 10685148
Rev Esp Enferm Dig. 2019 Mar;111(3):241-242
pubmed: 30746954
Ann Surg. 2018 Nov;268(5):709-711
pubmed: 30048330
Dig Surg. 2014;31(4-5):291-6
pubmed: 25342434
JAMA Surg. 2014 Dec;149(12):1319-22
pubmed: 25353279
J Pediatr Surg. 2014 Oct;49(10):1533-5
pubmed: 25280662
Eur J Vasc Endovasc Surg. 2017 Jun;53(6):886-894
pubmed: 28356209
Clin Gastroenterol Hepatol. 2011 Jul;9(7):567-76.e1-4
pubmed: 21397732
Gastroenterol Clin North Am. 2015 Mar;44(1):151-67
pubmed: 25667030
Nat Rev Dis Primers. 2018 Nov 1;4(1):41
pubmed: 30385743
J Gastrointest Surg. 2009 Oct;13(10):1870-3
pubmed: 19357930
Gastroenterol Res Pract. 2012;2012:935721
pubmed: 22988453
Gastroenterol Clin North Am. 2015 Mar;44(1):59-68
pubmed: 25667023
Int Surg. 1995 Oct-Dec;80(4):322-7
pubmed: 8740677
Eur J Gastroenterol Hepatol. 2008 Jun;20(6):578-82
pubmed: 18467920
Am J Gastroenterol. 2018 May;113(5):647-659
pubmed: 29545633
Ann Surg. 1958 Nov;148(5):725-30
pubmed: 13595530
J Gastrointest Surg. 1999 Jan-Feb;3(1):15-21, discussion 21-3
pubmed: 10457319
Surg Endosc. 2013 Jan;27(1):61-6
pubmed: 22752276
Surgery. 2005 Mar;137(3):383-5
pubmed: 15746797
Gastrointest Endosc Clin N Am. 2019 Jan;29(1):85-95
pubmed: 30396530
J Pediatr Gastroenterol Nutr. 2008 Jan;46(1):92-5
pubmed: 18162841
BMC Gastroenterol. 2014 Feb 20;14:37
pubmed: 24555911
Mayo Clin Proc. 2010 Jun;85(6):552-9
pubmed: 20511485
J Gastrointest Surg. 2015 Mar;19(3):411-7
pubmed: 25575765
Ann R Coll Surg Engl. 2017 Jul;99(6):472-475
pubmed: 28660836
J Gastrointest Surg. 2018 Apr;22(4):713-721
pubmed: 29185149
Rev Esp Enferm Dig. 2017 Jan;109(1):62-63
pubmed: 28100057
Clin Anat. 2014 Nov;27(8):1244-52
pubmed: 23959808
Surg Endosc. 2015 May;29(5):1137-44
pubmed: 25701058
J Gastrointest Surg. 2012 Dec;16(12):2203-11
pubmed: 23076975
Surg Endosc. 2015 Apr;29(4):992-4
pubmed: 25115864
J Pediatr Surg. 2011 Dec;46(12):e29-31
pubmed: 22152903
Ann Surg. 1907 Nov;46(5):736-62
pubmed: 17862069
Anesthesiology. 1978 Oct;49(4):233-6
pubmed: 697075
J Comput Assist Tomogr. 2007 Sep-Oct;31(5):728-31
pubmed: 17895784
Clin Case Rep. 2017 Dec 27;6(2):323-329
pubmed: 29445471
Gastroenterology. 2016 May;150(6):1380-92
pubmed: 27147122
J Clin Gastroenterol. 2007 Jan;41(1):62-5
pubmed: 17198067
J Gastrointest Surg. 2019 May;23(5):997-1005
pubmed: 30291587
Dig Surg. 2007;24(3):149-56
pubmed: 17476104

Auteurs

Javier A Cienfuegos (JA)

Department of General Surgery, Clínica Universidad de Navarra, School of Medicine, University of Navarra, Av. Pío XII, 36, 31008, Pamplona, Spain. fjacien@unav.es.
Institute of Health Research of Navarra (IdisNA), Pamplona, Spain. fjacien@unav.es.
CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III, 31008, Pamplona, Spain. fjacien@unav.es.

Luis Hurtado-Pardo (L)

Department of General Surgery, University and Polytechnic La Fe Hospital, Valencia, Spain.

Víctor Valentí (V)

Department of General Surgery, Clínica Universidad de Navarra, School of Medicine, University of Navarra, Av. Pío XII, 36, 31008, Pamplona, Spain.
Institute of Health Research of Navarra (IdisNA), Pamplona, Spain.
CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III, 31008, Pamplona, Spain.

Manuel F Landecho (MF)

Institute of Health Research of Navarra (IdisNA), Pamplona, Spain.
CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III, 31008, Pamplona, Spain.
Department of General Surgery, University and Polytechnic La Fe Hospital, Valencia, Spain.
Department of Internal Medicine, Clínica Universidad de Navarra, School of Medicine, University of Navarra, Pamplona, Spain.

Isabel Vivas (I)

Institute of Health Research of Navarra (IdisNA), Pamplona, Spain.
CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III, 31008, Pamplona, Spain.
Department of General Surgery, University and Polytechnic La Fe Hospital, Valencia, Spain.
Department of Internal Medicine, Clínica Universidad de Navarra, School of Medicine, University of Navarra, Pamplona, Spain.
Department of Radiology, Clínica Universidad de Navarra, School of Medicine, University of Navarra, Pamplona, Spain.

Mateo G Estévez (MG)

Department of Radiology, Hospital Universitario Gregorio Marañón, Universidad Complutense de Madrid, Madrid, Spain.

Alberto Diez-Caballero (A)

Department of General Surgery, Centro Médico Teknon, Barcelona, Spain.

José Luis Hernández-Lizoáin (JL)

Department of General Surgery, Clínica Universidad de Navarra, School of Medicine, University of Navarra, Av. Pío XII, 36, 31008, Pamplona, Spain.
Institute of Health Research of Navarra (IdisNA), Pamplona, Spain.

Fernando Rotellar (F)

Department of General Surgery, Clínica Universidad de Navarra, School of Medicine, University of Navarra, Av. Pío XII, 36, 31008, Pamplona, Spain.
Institute of Health Research of Navarra (IdisNA), Pamplona, Spain.
CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III, 31008, Pamplona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH